Bogart Wealth’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.54K Hold
17
– – ﹤0.01% 1558
2026
Q2
$652 Hold
17
– – ﹤0.01% 1712
2026
Q1
$361 Buy
+17
New +$340 ﹤0.01% 1654
2023
Q1
– Sell
-15
Closed -$547 – 1207
2022
Q4
$547 Hold
15
– – ﹤0.01% 909
2022
Q3
$0 Sell
15
-8
-35% -$305 ﹤0.01% 1140
2022
Q2
$1K Buy
23
+8
+53% +$415 ﹤0.01% 873
2022
Q1
$1K Hold
15
– – ﹤0.01% 766
2021
Q4
$2K Hold
15
– – ﹤0.01% 675
2021
Q3
$2K Buy
+15
New +$2.58K ﹤0.01% 653

Other funds holding TXG

Bogart Wealth's TXG Position: Q3 2026 in Review

Bogart Wealth held its 10x Genomics (TXG) position steady in Q3 2026 at 17 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1558.

Bogart Wealth first reported a position in TXG in Q3 2021 and has held it in 9 quarters since. The position peaked at $2K in Q4 2021. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Bogart Wealth held 17 shares of 10x Genomics worth $1.54K as of Q3 2026.
  • Bogart Wealth left its 10x Genomics share count unchanged in Q3 2026.
  • 10x Genomics made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1558 holding.
  • Bogart Wealth first reported a position in 10x Genomics in Q3 2021 and has held it in 9 quarters since.
  • Bogart Wealth's 10x Genomics position peaked at $2K in Q4 2021.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.